Log In
Print this Print this

Precose, acarbose (BAYG5421)

  Manage Alerts
Collapse Summary General Information
Company Bayer AG
DescriptionOral alpha glucosidase inhibitor
Molecular Target Acid alpha glucosidase (GAA)
Mechanism of ActionAlpha glucosidase inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationDiabetes
Indication DetailsDelay/prevent Type II diabetes
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today